Speakers

Links

Important Dates

Last date for full Submission Deadline :

May 20,2022

Last date for full Notification of Acceptance :

May 30,2022

Last date for full Camera Ready Submission:

June 10,2022

Contact Us

Ms. Su

Tel: +86-15393713197

Email:icbeps@iaast.cn

Keynote Speakers

  • Heng Li

    Research field:Development and research of research and development of natural drugs, development of traditional Chinese medicine preparations and natural drug health products.

    Professor, licensed pharmacist, senior engineer, Fujian Vocational College of Bio-engineering.

    Heng, Li received the B.S.degree in traditional Chinese medicine from the Department of Traditional Chinese Medicine of Heilongjiang University of Traditional Chinese Medicine, China, in 1991. And he received master' s degree in 2009. He is currently an professor at the Fujian Vocational College of Bio-engineering, Fu Jian, China. He is also an innovation and entrepreneurship tutor, an innovation and entrepreneurship evaluation expert for college students, a vice chairman of the Chinese Medicine Professional Committee of the Chinese Commodity Society, and a standing director of the Chinese Medicine Identification Professional Committee of the World Federation of Chinese Medicine Societies. Hie research interests include the development and research of research and development of natural drugs, development of traditional Chinese medicine preparations and natural drug health products.

  • Yuming Xu

    Research field:Skeletal muscle function, Physical Fitness and Intelligent Management of Sports Health, Intelligent sports product research and development.

    Professor,Hangzhou Normal University.

    Director of National Virtual Simulation experiment Teaching Center for Scientific Fitness and Sports skills. National fitness public service expert. Major: Kinesiology, Sport and Exercise Science. Research field: Skeletal muscle function, Physical Fitness and Intelligent Management of Sports Health, Intelligent sports product research and development.

  • Fangdong Li

    Research field:New cultivar selection and high-yielding cultivation techniques of non-timber forestry, breeding population establishment and genetic improvement of Paulownia.

    Professor, Chief Scientist, Chinese Academy of Forestry.

    Fangdong Li's research fields focused on new cultivar selection and high-yielding cultivation techniques of non-timber forestry, breeding population establishment and genetic improvement of Paulownia. He has been incharged of implementations of more than 20 scientific projects from state level to provincial, including national "twelfth five-year" plan of science and technology support program of China "Research and demonstration of key technology of high yielding of non-timber forestry", etc. in recent years, he became a project leader of "thirteenth five-year" science and technology support program "the National Key R&D Program of China". He achieved 6 scientific awards including one first prize awarded by Henan province, one second national, and 16 national invented patents, and registered 26 cultivars. He published over 80 papers and 3 books.

  • Cheng Ming

    Research field:Rehabilitation diagnosis and treatment of orthopaedic diseases after operation and conservative treatment.

    Deputy Chief Physician, Sichuan Provincial People' s Hospital.

    Cheng Ming,Deputy Chief Physician, Doctor of Sports Rehabilitation, Leader of Orthopedic Rehabilitation Group of Sichuan Provincial People' s Hospital, Director of Rehabilitation Department of Jinniu Hospital of Sichuan Provincial People' s Hospital. Mainly engaged in rehabilitation diagnosis and treatment of orthopaedic diseases after operation and conservative treatment.

  • Te Kian Keong

    Research field:Bone and joint diseases, COVID-19, communicable diseases.

    Associate Professor, Univerisiti Tunku Abdul Rahman (UTAR). 

    Te Kian Keong received his Bachelor of Medicine (Chinese Medicine) from the Shanghai University of Traditional Chinese Medicine in 2003. And he received PhD degree in Chinese Medicine from the Nanjing University of Chinese Medicine in 2012. He is currently an Associate Professor at the M. Kandiah Faculty of Medicine and Health Sciences, UTAR and Director of UTAR Traditional and Complementary Medicine Centre. His research interests include bone and joint diseases, COVID-19, communicable diseases, etc.

  • Dongsheng Yang

    Research field:Associate Professor, College of Pharmacy and Food Science, Zhuhai College of Science and Technology.

    Dongsheng Yang graduated from Jilin University with a doctorate in Biochemistry and Molecular Biology. Currently, Vice Dean of School of Pharmacy and Food Science, Zhuhai Institute of Science and Technology, chaired and participated in more than 20 scientific research and teaching reform projects, and presided over 10 projects, including one provincial project; published 24 papers as the first author, including the form of 16 SCI articles and 3 dissertations on academic research; filed 6 patents and co-edited 5 monographs and 8 lecture boards. Meanwhile, an expert member of the Professional Committee of Medicinal Wine of the Chinese Society of Traditional Chinese Medicine, a member of the Professional Committee of the Evaluation and Utilization of Medicinal Food and Drug Substances of the Chinese Medicine Association of Guangdong Province, a standing member of the Professional Committee of Lingnan Chinese Herbal Resources of the Guangdong Pharmaceutical Society, a director of the Chinese Ethnic Medicine Industry Association of Macau, a vice president of the Zhuhai Pharmaceutical Industry Association and a vice chairman of the Pharmaceutical Professional Committee of the Zhuhai Pharmaceutical Society.

  • Hongzhu Guo

    Research field:Composition analysis and safety research of traditional Chinese medicine.

    Chief Pharmacist, Beijing Institute for Drug Control.

    Hongzhu Guo is Chief Pharmacist, Beijing Institute for Drug Control, NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drugs, Beijing Key Laboratory of Analysis and Evaluation on Chinese Medicine. Hongzhu Guo, received Ph.D.degree from Beijing University of Chinese Medicine in 1996. Current member of the Chinese Pharmacopoeia Commission. Chief Pharmacist of the Beijing Institute for Drug Control. The research direction is the composition analysis and safety research of traditional Chinese medicine.

  • Nanda Gopal Sahoo

    Research field:

    Professor, Nanoscience and Nanotechnology Centre, Department of Chemistry, Kumaun University (D.S.B.) Campus, India

    Prof. Nanda Gopal Sahoo is serving as a Professor in Department of Chemistry, Kumaun University. And he is In-Charge of Nanoscience and Nanotechnology Centre. Prof. Nanda Gopal Sahoo has national and international working experience of more than ten years at biomedical and material science. He also served as the editor in chief of the Journal of Advances in Medicine Science, and the guest editor of the International Journal of Polymer Science, Journal of Spectroscopy. He is also serving as an Editorial Board Member to 10 reputed and indexed international journals and serving as reviewer for more than 30 international journals. Prof. Nanda Gopal Sahoo has published more than 100 research articles in related international journals and conferences. He has got the honors as the fellow of Royal Society of Chemistry (FRSC), the World’s Top 2% Scientist, and the Brand Ambassador for Bentham Science Publisher. Prof. Nanda Gopal Sahoo also been invited to serve as Keynote Speaker/Plenary/Invited Lecture in more than 20 conferences and organizations.

  • Alessandro Parodi

    Research field:Drug formulation; Nanomedicine; Drug delivery.

    Associate Professor, Sechenov First Moscow State Medical University, Russia; Leading scientist, Sirius University of Science and Technology, Russia.

    Dr. Parodi received his master's degree in Biological Science in 2004 and his PhD in Pharmaceutical, Cosmetic, and Food Science in 2008 at the Universita’ degli studi di Genova (Italy). He developed significant experience in drug formulation, nanomedicine, and drug delivery. He is currently holding the position of Associate Professor at Sechenov University (Moscow) and the position of a Leading Scientist at Sirius University (Sochi) where he is developing novel approaches to translate current concepts of PK to nanoparticles and to evaluate lysosomal degradation by using protein nanoparticles. In his career, he investigated the cellular impact and the drug delivery properties of different delivery platforms, including lipid, polymeric, silica, carbon nanotubes and protein nanoparticles. 

  • Stalis Norma Ethica

    Research field: Microbial biotechnology; Environmental toxicology; Biochemistry.

    Dr. Stalis Norma Ethica M.Si. (Orcid ID: 0000-0002-0853-0423) is a full-time lecturer and researcher with industrial laboratory experience. She focuses in the utilization of bacterial cells and enzymes as bioremediation, medicinal, and diagnostic agents, using encapsulation and genetic engineering technologies to support her work. Dr. Ethica graduated from Universitas Gadjah Mada in Indonesia with a bachelor's and master's degree in chemistry. In 2014, she received her doctorate in Biotechnology from the same university. In 2018 she pursued the Advanced Course in Next Generation Sequencing Bioinformatics (EMBL-EBI) at the Wellcome Genome Campus in Cambridge, UK. In 2015, she became a lecturer at Universitas Muhammadiyah Semarang's Undergraduate Program in Medical Laboratory Technology. She has been a full-time lecturer (assistant professor) in the Postgraduate Program of Magister of Clinical Medicine since 2019. The Indonesian Ministry of Research and Higher Technology funded her work on developing bioremediation agents for hospital wastewater from indigenous bacteria and developing antithrombosis and antibiofilm agents from marine bacterial enzymes.